Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$320.68M+28.2%$250.17M-7.3%$269.74M
$44.96M-0.2%$45.04M+0.7%$44.74M
$389.07M+26.1%$308.43M-2.5%$316.4M
$1.53M-3.2%$1.58M-3.3%$1.64M
$393.48M+25.7%$312.93M-2.4%$320.75M
$7.12M+235%$2.13M-17.9%$2.59M
$10.91M+46.5%$7.44M+12.0%$6.65M
$14.79M+27.2%$11.62M+10.4%$10.53M
$3K0.0%$3K-100.0%$114.3M
-$148.58M-14.7%-$129.53M-9.7%-$118.06M
$378.69M+25.7%$301.31M-2.9%$310.22M+399%-$103.87M-4.6%-$99.34M-5.1%
$393.48M+25.7%$312.93M-2.4%$320.75M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are LB Pharmaceuticals Inc Common Stock's total assets?
LB Pharmaceuticals Inc Common Stock (LBRX) holds $393.5M in total assets.
How much debt does LB Pharmaceuticals Inc Common Stock have?
LB Pharmaceuticals Inc Common Stock carries $3.5M in total debt against $378.7M of shareholders' equity, a debt-to-equity ratio of 0.01.
How much cash does LB Pharmaceuticals Inc Common Stock have?
LB Pharmaceuticals Inc Common Stock holds $320.7M in cash and equivalents.
Can LB Pharmaceuticals Inc Common Stock cover its short-term obligations?
Its current ratio is 35.68 — current assets exceed current liabilities.
Where does LB Pharmaceuticals Inc Common Stock's balance sheet data come from?
Every line is extracted from LB Pharmaceuticals Inc Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.